Business Development Intern – BIOVECTRA Business Development & Expansion Project

This project will focus on supporting BIOVECTRA’s organizational goals of solving complex therapeutic challenges in collaboration with partners through contract development and manufacturing. This project will specifically focus on the current expansion challenges associated with a rapidly developing CDMO. This project will address the challenges of resource allocation and financial planning as the company continues to expand and transform. This will include the assessment and maintenance of positive cash flows and profitability, development of an appropriate scaling strategy to meet demand and client expectations, and the application of budget review and long-term financial projections to promote sustainability within a competitive, challenging and dynamic industry. This project will develop and utilize budget review, assembly, and projections to accurately analyze and predict strategy to ensure future success. Through this collaboration, BIOVECTRA will benefit from the skill sets of the intern and the academic supervisor, while also contributing to the training of HQP.
This project will result in the generation of three reports; including Report 1: 2023 Budget Review & 2024 Revenue Budget Assembly & Analysis, Report 2: Revenue projections for new Canadian Manufacturing Facility and Report 3: Long-term Revenue Forecast. These reports will serve as supporting materials to provide BIOVECTRA with functional financial metrics to appropriately analyze the 2023 and 2024 budget while determining long-term projections to ensure sustainable growth.

Faculty Supervisor:

Dan Shaw

Student:

Partner:

BIOVECTRA Inc.

Discipline:

Business

Sector:

Biomanufacturing; Pharmaceuticals

University:

Dalhousie University

Program: